RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $0 | – | 25 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 25 | -99.8% | 0.00% | – |
Q3 2022 | $7,000 | -46.2% | 16,548 | +10.3% | 0.00% | – |
Q2 2022 | $13,000 | +225.0% | 15,002 | +1908.3% | 0.00% | – |
Q1 2022 | $4,000 | -95.7% | 747 | -92.1% | 0.00% | -100.0% |
Q4 2021 | $92,000 | -45.9% | 9,417 | -0.9% | 0.00% | -50.0% |
Q3 2021 | $170,000 | +95.4% | 9,505 | +167.2% | 0.00% | +100.0% |
Q2 2021 | $87,000 | 0.0% | 3,557 | +7.7% | 0.00% | +100.0% |
Q1 2021 | $87,000 | +200.0% | 3,302 | -14.1% | 0.00% | 0.0% |
Q4 2020 | $29,000 | -83.1% | 3,843 | -88.8% | 0.00% | -50.0% |
Q3 2020 | $172,000 | +196.6% | 34,340 | +255.4% | 0.00% | 0.0% |
Q2 2020 | $58,000 | +1833.3% | 9,663 | +1543.4% | 0.00% | – |
Q1 2020 | $3,000 | -95.3% | 588 | -91.3% | 0.00% | -100.0% |
Q4 2019 | $64,000 | +814.3% | 6,722 | +650.2% | 0.01% | – |
Q3 2019 | $7,000 | -89.6% | 896 | -79.1% | 0.00% | -100.0% |
Q2 2019 | $67,000 | +204.5% | 4,278 | +210.7% | 0.01% | +150.0% |
Q4 2018 | $22,000 | – | 1,377 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
Caption Management, LLC | 86,000 | $652,000 | 0.02% |
Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |